BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 205 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,783,374 | -51.4% | 75,336 | -38.9% | 0.01% | -45.5% |
| Q2 2023 | $7,787,694 | +3379.4% | 123,223 | +2376.8% | 0.01% | – |
| Q1 2023 | $223,825 | +2.1% | 4,975 | -0.6% | 0.00% | – |
| Q4 2022 | $219,181 | -33.4% | 5,003 | -0.0% | 0.00% | -100.0% |
| Q3 2022 | $329,000 | -2.9% | 5,005 | -22.8% | 0.00% | 0.0% |
| Q2 2022 | $339,000 | -91.6% | 6,484 | -89.8% | 0.00% | -80.0% |
| Q1 2022 | $4,059,000 | -66.0% | 63,538 | -42.6% | 0.01% | -66.7% |
| Q4 2021 | $11,933,000 | +7.5% | 110,664 | +2.5% | 0.02% | 0.0% |
| Q3 2021 | $11,101,000 | -6.3% | 107,958 | -19.9% | 0.02% | -6.2% |
| Q2 2021 | $11,853,000 | -36.3% | 134,759 | -29.6% | 0.02% | -42.9% |
| Q1 2021 | $18,621,000 | +11.0% | 191,506 | +28.0% | 0.03% | 0.0% |
| Q4 2020 | $16,772,000 | +3254.4% | 149,558 | +2676.3% | 0.03% | +2700.0% |
| Q3 2020 | $500,000 | +38.1% | 5,387 | +16.1% | 0.00% | 0.0% |
| Q2 2020 | $362,000 | +39.8% | 4,641 | +4.8% | 0.00% | 0.0% |
| Q1 2020 | $259,000 | -28.5% | 4,428 | -2.0% | 0.00% | 0.0% |
| Q4 2019 | $362,000 | +10.0% | 4,518 | +0.9% | 0.00% | 0.0% |
| Q3 2019 | $329,000 | -81.7% | 4,479 | -76.5% | 0.00% | -66.7% |
| Q2 2019 | $1,801,000 | +159.5% | 19,096 | +120.1% | 0.00% | +200.0% |
| Q1 2019 | $694,000 | +199.1% | 8,675 | +100.9% | 0.00% | – |
| Q4 2018 | $232,000 | -31.6% | 4,317 | -0.6% | 0.00% | – |
| Q3 2018 | $339,000 | +17.7% | 4,341 | -4.2% | 0.00% | – |
| Q2 2018 | $288,000 | -33.5% | 4,531 | -4.1% | 0.00% | -100.0% |
| Q1 2018 | $433,000 | +25.5% | 4,727 | +3.3% | 0.00% | – |
| Q4 2017 | $345,000 | -0.9% | 4,574 | -8.4% | 0.00% | – |
| Q3 2017 | $348,000 | -90.8% | 4,994 | -93.3% | 0.00% | -100.0% |
| Q2 2017 | $3,770,000 | +444.8% | 74,404 | +330.0% | 0.01% | +500.0% |
| Q1 2017 | $692,000 | +51.1% | 17,304 | +6.0% | 0.00% | 0.0% |
| Q4 2016 | $458,000 | – | 16,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |